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ABSTRACT 1 
Dendrimers are synthetic macromolecules composed of repetitive layers of branching units 2 
that emerge from a central core. They are characterized by a tunable size and precise number of 3 
peripheral groups which determine their physicochemical properties and function. Their high 4 
multivalency, functional surface and globular architecture with diameters in the nanometer scale 5 
makes them ideal candidates for a wide range of applications. GATG (gallic acid-triethylene 6 
glycol) dendrimers have attracted our attention as a promising platform in the biomedical field 7 
because of their high tunability and versatility. The presence of terminal azides in GATG 8 
dendrimers and PEG-dendritic block copolymers allows their efficient functionalization with a 9 
variety of ligands of biomedical relevance including, anionic and cationic groups, 10 
carbohydrates, peptides or imaging agents. The resulting functionalized dendrimers have found 11 
application in drug and gene delivery, as antiviral agents and for the treatment of 12 
neurodegenerative diseases, in diagnosis and as tools to study multivalent carbohydrate 13 
recognition and dendrimer dynamics. Herein we present an account on the preparation and 14 
recent applications of GATG dendrimers in these fields. 15 
 16 
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ABBREVIATIONS: AMCA, Aminomethylcoumarin; CA, HIV capsid protein; CTD, C-19 
Terminal domain; Con A, Concanavalin A; CuAAC, Cu(I)-catalyzed azide-alkyne 20 
cycloaddition; DTPA, Diethylenetriaminepentacetate; DOTA, 1,4,7,10-Tetraazacyclododecane-21 
1,4,7,10-tetraacetic acid; DO3A, Tri-tert-butyl 1,4,7,10-tetraazacyclododecane-1,4,7-triacetate; 22 
EGFP, Enhanced green fluorescent protein; FDA, Food and drug administration; FITC, 23 
Fluorescein isothiocyanate; GATG, Gallic acid-triethylene glycol; Gn, Dendrimer generation, n 24 
denotes the generation number; Glc, Glucose; HEK293T, Human embryonic kidney cell line 25 
293T; HIV, Human immunodeficiency virus; HPMA, N-(2-hydroxypropyl)methacrylamide; 26 
HSV, Herpes simplex virus; ITC, Isothermal titration calorimetry; Man, Mannose; Mor, 27 
Morpholine; MRI, Magnetic resonance imaging; NOE, Nuclear Overhauser effect; PAMAM, 28 
Polyamidoamine; PEG, Poly(ethylene glycol); PPI, Polypropyleneimine; PIC, Polyion complex; 29 
RGD, Arginylglycylaspartic acid; SPR, Surface plasmon resonance. 30 
 31 
INTRODUCTION 32 
Dendrimers are synthetic tree-like macromolecules composed of repetitive layers of 33 
branching units that emerge from a central core (Fig. 1). They are synthesized in a controlled 34 
iterative fashion through generations with nil dispersity, precise molecular weight, and discrete 35 
properties (1-3). Their high functional surface, globular architecture in the nanometer scale, and 36 
inherent multivalency makes them ideal candidates for a wide range of applications, from bio- 37 
and nanotechnology (4-8) to catalysis and materials science (9-11). The first reports on 38 
dendrimers were published independently in the late 70s and early 80s of the last century by the 39 
groups of Vögtle (12), Newkome (13), and Tomalia (14). Since then, over a hundred dendritic 40 
architectures have been described in the search of improved and novel properties. Among them, 41 
recognized dendritic families include polyamidoamine (PAMAM) (15), polypropyleneimine 42 
(PPI) (16), and others based on polyamide (13), polyether (17), polyester (18, 19), and 43 
phosphorous-based (20) scaffolds.  44 
Recently, we have turned our attention to the GATG (gallic acid-triethylene glycol) dendritic 45 
family as a promising platform in the biomedical field (Fig. 1). GATG dendrimers, first 46 
described by the group of Roy (21-23), are composed of a repeating unit carrying a gallic acid 47 
core and hydrophilic triethylene glycol arms with terminal azide groups. Advantage of the 48 
azides is taken for the dendritic generation growth, easily accomplished by a reduction/amide 49 
coupling sequence, as well as for the dendrimer decoration by means of the Cu(I)-catalyzed 50 
azide-alkyne cycloaddition (CuAAC) (24-28) as demonstrated by our group. As part of our 51 
effort to develop the biomedical applications of GATG, we have also described the 52 
incorporation of the FDA-approved poly(ethylene glycol) (PEG) at the focal point of dendritic 53 
wedges to render PEG-GATG block copolymers with increased solubility and stealth properties. 54 
PEG-dendritic block copolymers constitute interesting hybrid structures where differences in the 55 
solubility properties of the blocks can be exploited in the preparation of micelles and other 56 
nanostructures of biomedical interest (29-31). 57 
Herein we present an account of our journey with GATG that focuses on recent examples in 58 
the fields of drug and gene delivery, diagnosis, and antiviral activity, as well as the use of 59 
GATG as tools to study biological processes and the dynamics of dendrimers. 60 
 61 
SYNTHESIS OF GATG DENDRIMERS AND PEGYLATED BLOCK COPOLYMERS 62 
GATG dendrimers ([Gn]-N3, where n is the generation number) are synthesized divergently 63 
from a repeating unit shown in Fig. 1, following a straightforward azide reduction/amide 64 
coupling sequence. Initial reports by the group of Roy in the 90’s described GATG 65 
sialodendrimers and dendronized chitosans up to the second generation (G2) as promising 66 
microbicides (21-23). Nevertheless, the synthesis of the repeating unit (four steps from 67 
triethylene glycol, 23% overall yield) proved to be a hurdle in accessing large quantities and 68 
higher G of these dendrimers, which finally hampered their subsequent development. 69 
Aware of these limitations, in 2006 our research group described an improved preparation of 70 
this repeating unit from commercially available chlorotriethylene glycol in 77% overall yield 71 
(32). By observing green chemistry principles (atom economy, safety, waste reduction), this 72 
synthetic route has been further developed for the cost-effective production of the repeating unit 73 
in batches larger than 100 g in excellent overall yield (86%) and purity (Fig. 1) (33). With an 74 
easy and scalable access to the repeating unit, the preparation of GATG dendrimers and PEG-75 
dendritic block copolymers has been efficiently achieved in large quantities up to G4 (243 76 
peripheral azides) (32, 34, 35). The PEGylated block copolymers are synthesized following a 77 
"chain first" approach where the PEG is initially incorporated at the focal point of a GATG 78 
repeating unit and then, the higher G obtained divergently. Noteworthy, PEG facilitates the 79 
purification steps in the synthesis of the block copolymers thanks to its properties as a soluble 80 
polymeric support (36). As mentioned, the surface functionalization of GATG dendrimers and 81 
block copolymers by CuAAC with unprotected ligands (carbohydrates, anionic and cationic 82 
moieties, peptides, imaging agents) has proceeded straightforward in our hands, allowing the 83 
preparation of a variety of functional dendritic structures of biomedical interest that will be 84 
presented in the following sections.  85 
 86 
CELLULAR INTERNALIZATION OF GATG DENDRIMERS 87 
Dendrimers have traditionally found great attention in targeted drug delivery, particularly for 88 
cancer therapy and diagnosis (5, 6). The high number of functional groups on their periphery 89 
allows the simultaneous incorporation of bioactive molecules, cytostatic drugs, diagnostic 90 
probes and targeting ligands. In addition, the combination of high water solubility and 91 
hydrophobic cores is well suited for the covalent attachment or physical encapsulation of large 92 
payloads of therapeutic molecules. Cellular uptake of dendrimer-based drug delivery systems 93 
has proved significantly higher than that of linear polymeric carriers (37, 38), which can be 94 
explained on the basis of their compact nano-sized architecture in solution. 95 
In order to explore the versatility of PEG-GATG block copolymers as tools in the 96 
biomedical field, we have analyzed in collaboration with Albertazzi their cellular internalization 97 
and intracellular fate (39), both properties of particular interest in drug delivery. To this aim, a 98 
PEGylated block copolymer of third generation (PEG-[G3]-N3) was functionalized via CuAAC 99 
with different peripheral groups, including neutral and charged moieties, biologically active 100 
carbohydrates, and peptides. All dendritic structures were labeled with fluorescein (FITC), and 101 
the effect of the surface functionalization on cell-uptake and intracellular trafficking was studied 102 
by confocal microscopy in HeLa cells. It was observed that, while cationic PEG-[G3]-NH3+ 103 
showed a strong internalization consistent with its ability to bind cell membranes through ionic 104 
interactions, anionic PEG-[G3]-OSO3− displayed only a weak internalization because of its 105 
lower affinity for cell membranes. This behavior was even more evident for a neutral acetylated 106 
PEG-[G3]-NHAc that exhibited no internalization at all. In addition, the intracellular final fate 107 
of PEG-[G3]-NH3+ was tracked, revealing colocalization with lysosomes. The effect of the 108 
surface functionalization with biologically relevant ligands, such as lactose and a cyclic RGD 109 
peptide was also investigated (39). Confocal microscopy and flow cytometry assays showed 110 
significant cellular uptake in HepG2 cells for dendritic structures decorated with lactose and in 111 
HeLa cells for those containing the RGD sequence. Based on these results, a prototype of drug 112 
carrier capable of selectively entering cells and specifically releasing its payload in the acidic 113 
lysosomal environment was designed from PEG-[G3]-NH3+. With this aim, a coumarin dye was 114 
bound through a pH-sensitive hydrazone linker to the dendritic platform (Fig. 2). The 115 
performance of this system was evaluated with a double fluorescent-labeling allowing for 116 
simultaneous monitoring the localization of the dendritic carrier (FITC) and the coumarin dye as 117 
a model cargo molecule (AMCA-hydrazide). Fluorescence experiments at short incubation 118 
times showed high colocalization between FITC and AMCA in the endolysosomal system. 119 
However, reduced colocalization and increased fluorescence intensity due to AMCA could be 120 
observed at longer incubation times (Fig. 2), which are consistent with a lysosomal hydrolysis 121 
of the hydrazone linkers and subsequent release of AMCA to the cytoplasm. This GATG-based 122 
conjugate accomplishes the main requirements for a successful drug delivery system (cell 123 
internalization, intracellular release, endosomal escape) and represents a promising proof-of-124 
principle for further applications of GATG dendrimers and block copolymers in drug delivery.  125 
 126 
GATG NANOSTRUCTURES FOR DRUG AND GENE DELIVERY 127 
PEG-GATG block copolymers are especially suited for drug and gene delivery applications. 128 
For instance, they have been used in the preparation of polyion complex (PIC) micelles. PIC 129 
micelles are smart delivery systems originally described by the groups of Kataoka and Kabanov 130 
(40, 41), that are formed by electrostatic interaction between oppositely charged polyions. 131 
Similarly to classical polymeric micelles, PIC micelles have a core-shell structure with a core of 132 
ionic blocks surrounded by a neutral hydrophilic corona, typically of PEG. Properties such as 133 
their small size, electrical neutrality, and narrow size distribution make these systems highly 134 
attractive for drug delivery applications (42, 43). 135 
Our research group has reported the preparation of nanosized PIC micelles from an anionic 136 
PEG-GATG block copolymer of G3 decorated with 27 peripheral sulfates and poly-L-lysine 137 
(PLL) as a model polymer of opposite charge (Fig. 3) (44). Notably, these micelles displayed 138 
enhanced stability towards ionic strength compared to conventional PIC micelles from linear 139 
copolymers, a fact has been ascribed to the more rigid dendritic architecture. These micelles are 140 
envisioned as attractive delivery systems for low molecular weight drugs, proteins, nucleic acids 141 
and imaging agents. In another example, making use of the developed CuAAC conditions for 142 
the anionic decoration of GATG dendrimers, carboxylates have been introduced onto the 143 
dendritic periphery of PEG-GATG copolymers, which has allowed the preparation of related 144 
pH-sensitive PIC micelles with potential applications in cancer therapy (45). 145 
Cationic synthetic carriers have been widely assayed in the last decade as an alternative to 146 
viral vectors for the delivery of nucleic acids (46). Among them, cationic dendrimers with the 147 
ability to electrostatically interact with negatively charged nucleic acids have received special 148 
attention (7, 47). The complexes, named dendriplexes, obtained from commercially available 149 
PAMAM and PPI dendrimers have been by far the most investigated ones. Unfortunately, some 150 
limitations have arisen, mainly associated to the excess of positive charge necessary to 151 
efficiently complex the genetic material, which results in aggregation with blood components 152 
and cytotoxicity. One strategy to overcome these limitations has been the use of PEGylated 153 
cationic block copolymers to mask the positive charge (48, 49). Similarly to PIC micelles, the 154 
positively charged dendritic block interacts with the negatively charged nucleic acid forming an 155 
inner core surrounded by a hydrophilic PEG corona. The obtained dendriplexes are sterically 156 
stabilized and present lower z-potential, reduced cytotoxicity, and increased circulation times. 157 
In light of these results, cationic GATG dendrimers and their block copolymers appeared to 158 
be excellent candidates for gene delivery applications. Amine-decorated GATG scaffolds are 159 
easily obtained by reduction of the terminal azides. This results in a high positive charge in 160 
physiological media and so, in the ability to condense and protect nucleic acids. In addition, the 161 
hydrophobic nature of the gallic acid was envisioned to enhance the cellular uptake and 162 
transfection efficiency of the dendriplexes. In collaboration with the group of Alonso, we have 163 
recently evaluated the ability of amino-functionalized GATG dendrimers and block copolymers 164 
to complex plasmid DNA (pDNA) (34, 50). As a result of an analysis of the influence of G, N/P 165 
ratio, and the presence/absence of PEG on the dendriplex size and z-potential, we have proposed 166 
these dendriplexes as core–shell nanostructures with sterically induced stoichiometry. A single 167 
pDNA condensed at the core surrounded by a shell of dendrimers with a stoichiometry 168 
determined by the core/dendrimer relative size: the higher the dendrimer G, the fewer the 169 
dendrimers that can be accommodated on the dendriplex surface (Fig. 4). Interestingly, in the 170 
case of PEG-dendritic block copolymers, this implies the possibility of tuning the PEG density 171 
on the dendriplex surface, which may be of interest to control the stealth properties for specific 172 
gene therapy applications. 173 
The stability, cytotoxicity and interaction with blood components of the dendriplexes were 174 
studied, along with their ability to transfect mammalian cells (50). It was revealed that the 175 
dendriplexes formed from GATG dendrimers are stable, biocompatible and do protect pDNA 176 
from degradation. More importantly, dendriplexes were effectively internalized by HEK-293T 177 
cells, which were successfully transfected. It was also observed that PEGylation remarkably 178 
influences the properties of the dendriplexes. As previously seen in other nanostructures, PEG 179 
improves the biocompatibility at the cost of a reduced cellular uptake (51). Our results 180 
highlighted that the PEGylation degree of nanostructures should be carefully adjusted in order 181 
to obtain an optimized stealth formulation without compromising the transfection efficiency. A 182 
straightforward approach for modulating the density of the PEG shell that ensured a successful 183 
transfection was developed by employing mixtures of GATG dendrimers and PEGylated 184 
copolymers for the preparation of the dendriplexes (Fig. 4). Further investigations, including in 185 
vivo studies, are planned to draw definite conclusions on the efficacy of this mixed stealth 186 
formulation in animal models. 187 
 188 
GATG DENDRIMERS AS DRUGS: INTERACTIONS WITH PROTEINS AND PEPTIDES 189 
Besides the aforementioned application of dendrimers as drug carriers, they can also act as 190 
drugs by themselves (8). For instance, several dendritic structures have shown promising 191 
antimicrobial and antibacterial activity that pave their way as alternatives to conventional 192 
antibiotics (52-54). Anionic dendrimers with anti-inflammatory properties (55, 56) or as agents 193 
for the multiplication of human natural killer cells (57) have been also described. The use of 194 
dendrimers as inhibitors of viral infections has been investigated as well, in particular against 195 
the human immunodeficiency (HIV) and herpes simplex viruses (HSV-1 and HSV-2) (58-60). 196 
VivaGelTM, a L-lysine-based dendritic microbicide decorated with anionic groups, undoubtedly 197 
constitutes the most relevant example. It has been evaluated in Phase II clinical trials as a 198 
vaginal gel for preventing/reducing transmission of HIV and genital herpes (61). There are also 199 
reports on the use of dendrimers that dissolve prion-protein aggregates and hamper fibril 200 
formation of prion and -amyloid (A) peptides (62, 63). 201 
In this context, our group together with those of Velázquez-Campoy and Neira were 202 
encouraged to explore the ability of GATG dendrimers to interact with HIV-1. We hypothesized 203 
that if dendrimers can destabilize the tertiary structure of proteins, they could also disrupt the 204 
quaternary structure of the capsid protein CA of HIV-1 and hamper its assembly to form the 205 
viral capsid. Thus, CA has recently emerged as a promising target for the development of new 206 
anti-HIV drugs based on its critical role during HIV morphogenesis (64). Our results 207 
demonstrate that G1 GATG dendrimers bind to the C-terminal domain of CA (CTD) with a 208 
dissociation constant in the micromolar range, as shown by isothermal titration calorimetry 209 
(ITC) (65). The affinity of some of the dendrimers for CTD was similar to that of synthetic 210 
peptides binding the dimerization region, and of comparable magnitude to the 211 
homodimerization affinity of both CTD and CA. More importantly, a G1 dendrimer decorated 212 
by CuAAC with peripheral benzoate groups ([G1]-CO2Na) was able to hamper the assembly of 213 
the HIV capsid in vitro (Fig. 5), in what represents the first example of a dendrimer as a lead 214 
compound for the development of anti-HIV drugs targeting the capsid assembly. 215 
Nanomedicine has shown great potential for the treatment of many central nervous disorders, 216 
such as brain cancer, epilepsy, Alzheimer´s or Parkinson´s diseases. Among the different 217 
nanostructures employed for this purpose, dendrimers have been intensively investigated in 218 
neurodegenerative processes, especially Alzheimer’s disease (66). According to the amyloid 219 
cascade hypothesis, amyloid peptide aggregation is closely related to the onset and development 220 
of Alzheimer’s disease. Since Aβ peptide oligomers intermediate in the assembly of fibrils are 221 
more neurotoxic than the end products, novel strategies aimed to reduce their toxic effects by 222 
affecting the aggregation process are of much relevance (62, 67, 68). Encouraged by the 223 
promising properties of GATG dendrimers as inhibitors of the dimerization of CA, we 224 
envisaged GATG interfering in the formation of amyloid fibrils. In a joint effort with the group 225 
of Klajnert, a morpholine-decorated GATG dendrimer ([G3]-Mor) was identified to effectively 226 
accelerate the formation of amyloid fibrils from a Aβ 1-28 peptide (thioflavin T assay, CD, 227 
transmission electron microscopy) (Fig. 6) (69). Interestingly, when the cytotoxicity of the Aβ 228 
and the pair Aβ/[G3]-Mor was monitored at different stages of the aggregation process, it was 229 
observed that [G3]-Mor significantly reduced the toxicity of the peptide, most likely by 230 
speeding up the fibril formation and lowering the concentration of the toxic prefibrillar forms in 231 
the system. 232 
 233 
GATG GLYCODENDRIMERS AS TOOLS TO STUDY MULTIVALENT 234 
CARBOHYDRATE RECOGNITION 235 
Carbohydrates cover a large spectrum of bioactivities from energy source and structural roles 236 
to others crucial for the development, growth, function or survival of organisms. From bacteria 237 
to mammals, cells are coated with sugars as first points of contact with their environment. Thus, 238 
they are in a position to modulate a plethora of biological processes including, cell−cell 239 
recognition, fertilization, pathogen invasion, and toxin and hormone mediation. Moreover, 240 
strong evidence suggests that carbohydrates are key diagnostic and prognostic indicators as well 241 
as therapeutic targets (70). In addition, the clustered arrangement of carbohydrates on the cell 242 
surface enables their multivalent interaction in global processes characterized by affinities and 243 
specificities much higher than monovalent interactions (71, 72). This fact has prompted the 244 
development of synthetic multivalent glycoconjugates (linear polymers, micelles, nanoparticles, 245 
nanotubes, dendrimers) with the ability to promote/inhibit biological events (73). Since 246 
carbohydrate recognition is commonly mediated by proteins (lectins), the development of more 247 
efficient diagnostic and therapeutic tools relies on a better understanding of the 248 
carbohydrate−lectin interaction. However, the complexity of the binding mechanisms associated 249 
with multivalency (intermolecular crosslinking, chelation, statistical rebinding) makes them 250 
very difficult to measure experimentally. As a consequence, binding data are frequently 251 
extracted from indirect competitive methods in solution where only relative affinities are 252 
obtained (73). In addition, these experimental designs usually represent rough models for 253 
mimicking surface-based interactions as underestimate the multivalency derived from the lectin 254 
clustering. 255 
With the aim of gaining insight into the fundamental mechanisms of multivalent 256 
carbohydrate recognition we have synthesized GATG glycodendrimers by CuAAC from 257 
unprotected alkynated saccharides (Fig. 7) (32, 35). These were foreseen as nanotools of precise 258 
size and multivalency for mechanistic studies by surface plasmon resonance (SPR). We have 259 
compared the outcome of carbohydrate-lectin binding studies in solution (via competitive 260 
experiments) and surface-bound direct experiments (with immobilized lectins on a chip surface) 261 
(74, 75). To that end, we selected the lectin Concanavalin A (Con A) and four generations of 262 
glycodendrimers carrying 3-81 mannose/glucose residues ([Gn]-Man and [Gn]-Glc). Solution 263 
experiments demonstrated the importance of multivalency in carbohydrate recognition, with 264 
affinity increases being observed from the monosaccharide to G2. The lack of further affinity 265 
enhancements at higher G, however, contrasts with the surface-bound experiments. This 266 
different outcome not only stresses the relevance of the experimental design for soluble vs 267 
surface-bound lectins, but also that higher dendrimer G not necessarily result in higher affinities 268 
in solution. 269 
In the surface-bound experiments, a complex binding profile was disclosed with two limiting 270 
binding modes, a low-affinity mode associated with dendrimers binding the lectin surface 271 
monovalently, and a high-affinity mode associated with dendrimers with higher functional 272 
valency. SPR studies also revealed the dynamic nature of the binding mechanisms, with 273 
contributions depending on the glycoconjugate multivalency and lectin cluster density, but also 274 
on the local concentration of glycoconjugates in the proximity of the lectin cluster, which is a 275 
time-dependent factor (Fig. 7). As a result, an original SPR protocol was designed to gather 276 
kinetic and thermodynamic information on the interaction by analyzing the early association and 277 
late dissociation phases of the sensorgrams, areas where the low analyte concentration nearby 278 
the receptor surface favors the highest affinity binding modes. In addition, it was concluded that 279 
for surface-bound experiments, the density of receptors should be carefully selected to mimic as 280 
much as possible the biological environment if relevant quantitative information is desired 281 
beyond a list of relative affinities. 282 
 283 
GATG AS CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING 284 
Magnetic resonance imaging (MRI) uses a strong magnetic field and radio frequency pulses 285 
to obtain internal images of organs and lesions. Differences in contrast of the images reflect the 286 
rate at which excited protons of water molecules return to the equilibrium state (relaxation 287 
times, T) (76). Although it is possible to obtain high quality images by manipulation of pulse 288 
sequences, high contrast is better achieved by adding exogenous contrast agents that, upon 289 
coordination to water, accelerate relaxation. Contrast agents in the clinic are based on 290 
paramagnetic ions such as gadolinium (Gd3+) complexed to low molecular weight ligands (e.g.; 291 
DTPA, DOTA, DO3A) (77). These complexes present high relaxivity and adequate 292 
biocompatibility, stability and solubility. However, because of their small size they suffer from 293 
rapid excretion (high doses necessary) and passive distribution into the interstitial space. The 294 
use of macromolecular contrast agents is envisioned to provide longer circulation times in the 295 
bloodstream (adquisition windows) and selective diffusion through angiogenic tissue, along 296 
with an increased relaxivity per Gd (78). Among the macromolecular contrast agents, 297 
dendrimers are especially appealing because of their monodisperse nature and absolute control 298 
of their size. Their branched structure imparts rigidity and a high density of functional groups 299 
for the multivalent display of Gd and other synergistically integrated agents for therapy and 300 
diagnosis. In addition, the pharmacokinetics and pharmacodynamics of dendrimers, their 301 
permeability, excretion routes, and recognition by the reticulo-endothelial system can be 302 
controlled by generation (78-80). The synthesis of dendritic contrast agents has been 303 
conventionally achieved in a stepwise fashion through postlabeling approaches, which involve 304 
the incorporation of suitable ligands onto the macromolecular scaffold, followed by 305 
complexation to the desired metal ion. Unfortunately, these strategies suffer from incomplete 306 
functionalization that results in mixtures of polydisperse compounds and reduced relaxivity. To 307 
solve this inconvenience we have turned our attention to a prelabeling approach using Gd 308 
complexes and CuAAC as an efficient coupling technology. This way, the complete 309 
functionalization of three generations of PEG-GATG block copolymers was demonstrated with 310 
an alkynated Gd-DO3A complex (Fig. 8) (81). The resulting monodisperse macromolecular 311 
contrast agents, incorporating up to 27 Gd ions at the periphery, display molecular relaxivities 312 
that increase with G up to values in the range of Gadomer-17 (82), a polylysine-based dendritic 313 
contrast agents bearing 24 DO3A-Gd chelates and considered as a reference in the field. The 314 
analysis of the pharmacokinetic properties of this new family of PEG-dendritic contrast agents 315 
was studied in mice using a C6 glioma model (Fig. 8). After intravenous injection of the 316 
contrast agents, T1-weighted images showed similar increments of signal intensity and kinetic 317 
profiles to Gadomer-17 (with maximum intensities 4 min after injection), which reveals them as 318 
a promising platform for the development of dendritic contrast agents for MRI. The 319 
experimental simplicity of this CuAAC-based prelabeling approach should be of relevance for 320 
the preparation of alternative macromolecular metal complexes for applications in chemical 321 
exchange saturation transfer MRI, fluorescence imaging, and radiolabeling. 322 
 323 
DENDRIMER DYNAMICS  324 
The flexibility of the chemical bonds within dendrimers determines their internal dynamics, 325 
hydrodynamic size and topological localization of the external groups, all of relevance for 326 
pharmacological properties such as biodistribution and surface accessibility. In spite of initial 327 
controversies about the dendritic conformation, shape and packing, a consensus has recently 328 
emerged on dendrimers as flexible macromolecular structures with a dense core and fluctuating 329 
repeating unit groups (83). 330 
Nuclear magnetic resonance (NMR) is a powerful tool to study the dynamics of 331 
macromolecules at atomic level (84). Information is usually extracted by measuring longitudinal 332 
(T1) and transverse (T2) relaxation times and nuclear Overhauser effect (NOE). It is especially 333 
suited for the analysis of dendrimers since their repetitive nature offers the opportunity to probe 334 
different layers and G. Because of our interest in developing the bioapplications of GATG 335 
dendrimers, we decided to analyze their dynamical properties. With this aim we initially 336 
performed a 1H NMR relaxation study in CDCl3 (35). Increasing T1 and T2 values were observed 337 
on going from the core to the periphery that, according to the theoretical variation of relaxation 338 
times with the correlation time (τ) (Fig. 9) (85), were interpreted as a radial increase of 339 
dynamics in the same direction (congested core protons surrounded by more flexible external 340 
nuclei). This dynamical picture was later confirmed under more relevant aqueous conditions by 341 
a quantitative 13C relaxation study in collaboration with the group of Widmalm (86). 342 
In general, for NMR studies on the dynamics of macromolecules, quantitative modeling 343 
from 13C relaxation is preferred to 1H. However, lengthy 13C experiments and the necessity of 344 
recording various parameters at different magnetic fields have limited such approach in 345 
dendrimers to a single report apart from ours (86, 87). Conversely, a great deal of information 346 
has been extracted by qualitative interpretation of 1H and/or 13C relaxation. These studies have, 347 
nevertheless, afforded conflicting results on the relative dynamics between the dendritic core 348 
and the periphery. With the aim of throwing light on this controversy we have recently 349 
performed a comprehensive relaxation study (1H, 13C; various magnetic fields and temperatures) 350 
of Fréchet-type poly(aryl ether) dendrimers (Fig. 9) (17), as an example of a dendritic family 351 
where conflicting relative dynamics between core and periphery have been reported by 1H T1 352 
relaxation (88, 89) and by alternative techniques (90, 91). As a result of this work (92) it was 353 
revealed that NMR relaxation in dendrimers has been often misinterpreted in terms of dynamics. 354 
Dendrimers show slower dynamics at internal layers and display internal nuclei with T2 values 355 
shorter than the periphery, but T1 values that can be either shorter or larger depending on their 356 
position in the fast or slow motional regimes (Fig. 9). Accordingly, only the recording of T1 data 357 
at various temperatures (alternatively, T2 or NOE at one temperature) can ensure the correct 358 
interpretation of dendrimer dynamics. The large number of dendritic families, other than 359 
poly(aryl ether), where dynamics have been evaluated on the basis of T1 data at one temperature 360 
urges necessity of revisiting previous NMR relaxation studies. 361 
The fact that dendrimers obey a dense core model with increasing T2 values from the core to 362 
the periphery has been more recently exploited in our laboratory in T2-edited NMR experiments 363 
(93) for the stepwise filtering of the internal nuclei (94). The resulting filtered spectra benefit 364 
from reduced signal overlapping, which facilitates NMR assignment and characterization (Fig. 365 
10). This filtering strategy has been applied to various dendritic families, nuclei (1H, 13C, 31P) 366 
and 2D experiments (COSY and HSQC), and is envisaged to aid structural characterization and 367 
end-group analysis in related dendritic structures, including block, dendronized, and 368 
hyperbranched polymers functionalized with drugs, active targeting moieties and other labels. 369 
 370 
CONCLUSIONS 371 
GATG dendrimers and their PEGylated block copolymers represent promising 372 
macromolecular scaffolds for a plethora of biomedical applications. Key features in GATG are a 373 
high tunability and versatility. The presence of terminal azides in GATG allows their efficient 374 
functionalization with a variety of ligands of biomedical relevance. Depending on the desired 375 
application, GATG dendritic scaffolds have been easily decorated in a single step with anionic 376 
or cationic groups, carbohydrates, peptides or imaging agents. The resulting functionalized 377 
dendrimers have found application as nanotools to study multivalent interactions, as building 378 
blocks for the preparation of polymeric micelles and dendriplexes for gene delivery, as antiviral 379 
drugs or agents for the treatment of neurodegenerative diseases, and as contrast agents for MRI. 380 
In addition, the analysis of GATG dynamics by NMR relaxation has prompted a fundamental 381 
study on dendrimer dynamics. As a result, profound differences between the relaxation behavior 382 
of dendrimers and linear polymers were revealed that have been exploited in the filtering of 383 
NMR spectra to facilitate signal assignment and characterization. 384 
As a concluding remark, we would like to highlight that despite the promising results of 385 
GATG dendrimers in the biomedical field, there are still ahead of us fascinating puzzles to be 386 
solved where GATG might play a role. Examples of current challenges faced by this dendritic 387 
family in our laboratory are the development of nanosystems able to tackle unresolved problems 388 
in drug delivery and to avoid the limitations derived from the potential Cu contamination after 389 
CuAAC. Regarding the first objective, advantage can be taken of the modularity of GATG 390 
dendrimers. Indeed, by making discrete structural changes, such as varying the length of the 391 
PEG chain, the dendritic generation or the hydrophobicity at the periphery, the solubility and 392 
dynamical properties of GATG can be effectively tuned. As for the second challenge, we are 393 
currently engaged in the development of Cu-free approaches that circumventing the generation 394 
of reactive oxygen species, also avoid the use of large linkers like strained cycloalkynes. 395 
Finally, we are motivated to transfer GATG dendrimers to in vivo situations where parameters 396 
such as, biodegradability, immunogenicity or bioaccumulation, among others, will have to be 397 
carefully evaluated to validate their clinical potential. 398 
 399 
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LEGEND TO FIGURES 408 
 409 
 410 
Fig. 1. Structure, synthesis of the repeating unit, and applications of GATG dendrimers. 411 
Reprinted with permission from ref. (33). 412 
 413 
 414 
Fig. 2. Schematic structure of PEG-[G3]-AMCA-FITC-NH3+. Cell-uptake and intracellular 415 
trafficking in HeLa cells: fluorescent signals from FITC (carrier) and AMCA (model cargo). 416 
Reprinted with permission from ref. (39). 417 
 418 
 419 
Fig. 3. Schematic representation of the formation of PIC micelles from an anionic PEG-GATG 420 
block copolymer and PLL. DLS histogram and tapping-mode AFM image of the micelles. 421 
Reprinted with permission from ref. (44). 422 
 423 
 424 
Fig. 4 Schematic representation of dendriplexes prepared from a plasmid DNA (pDNA) and two 425 
generations of PEG-GATG block copolymers as nanostructures with core–shell stoichiometry. 426 
Expression of EGFP in HEK-293T cells transfected with dendriplexes prepared with increasing 427 
molar ratios of PEG-[G3]-NH2/[G3]-NH2: (a) 0% (solely G3), (b) 0.5%, (c) 1%, (d) 5%, (e) 428 
10%, (f) 20%, (g) 50% and (h) 100% (solely PEG-G3). Reprinted with permission from ref. 429 
(34) and (50). 430 
 431 
 432 
Fig. 5. Left: structure of [G1]-CO2Na. Centre: binding of GATG dendrimers to monomeric 433 
CTDW184A by NMR (residues in red change their peak intensities in the presence of GATG). 434 
Right: inhibitory activity of [G1]-CO2Na on the in vitro assembly of CA. Oligomerization of 435 
CA in the absence (black line) or presence of [G1]-CO2Na at a 5-fold (blue line) and 10-fold 436 
molar excess (red line). Reprinted with permission from ref. (65). 437 
 438 
 439 
Fig. 6. Left: structure of [G3]-Mor. Right: electron micrographs of Aβ 1-28 at the end of an 440 
aggregation process in the absence (A) and the presence of 1 μM [G3]-Mor (B). The length of 441 
the bar equals to 200 nm. Reprinted with permission from ref. (69). 442 
 443 
 444 
Fig. 7. Synthesis of GATG glycodendrimers and schematic representation of the dynamic 445 
binding heterogeneity of surface-bound experiments between lectin clusters and 446 
glycodendrimers: (a) Initial binding of glycodendrimers to the lectin cluster with potential 447 
stabilization via chelate mechanism depending on glycodendrimer size and lectin cluster 448 
density. (b) At longer association times, competition between dendrimers for lectin 449 
complexation increases, promoting monovalent interactions primarily stabilized via rebinding 450 
effects. (c) An initial fast dissociation of glycodendrimers bound with low affinity is followed 451 
by (d) a slower dissociation due to stabilization by rebinding and potential chelate effects. 452 
Reprinted with permission from ref. (32) and (75). 453 
 454 
 455 
Fig. 8. Schematic structure of PEG-GATG contrast agents for MRI. Normalized increase in 456 
signal intensity (ΔSI) in tumor and contralateral hemisphere. T1-weighted images of a mouse 457 
brain before (a) and after (b) administration of PEG-[G2]-(DO3A-Gd). Squares in images show 458 
tumor (right) and contralateral hemisphere (left) regions analyzed. Reprinted with permission 459 
from ref. (81). 460 
 461 
 462 
Fig. 9. Top left panel: structures of poly(aryl ether) dendrimers. Top right panel: schematic 463 
representation of the theoretical dependence of T1 and T2 on correlation time (τ). Bottom panel: 464 
1H T1 and T2 for the benzylic protons of G1–G4 poly(aryl ether) dendrimers (CDCl3, 500 MHz, 465 
298 K). Reprinted with permission from ref. (92). 466 
 467 
 468 
Fig. 10. Structure of G4 PAMAM and 1H T2-filtered NMR spectra (500 MHz, CDCl3, 298 K). 469 
Increasing filters between 150 ms and 1 s resulted in a spectrum showing only the most 470 
peripheral protons, which remained partially hidden in the original spectrum. Reprinted with 471 
permission from ref. (94). 472 
 473 
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